Welcome to the largest gathering for mRNA professionals
The highly anticipated event in the mRNA calendar, the mRNA-Based Therapeutics Summit returned for its second year in 2022 as the most comprehensive, industry-leading meeting for mRNA experts.
We provided exclusive data from the movers and shakers in mRNA vaccine and therapy development. Meanwhile, 370+ pioneers from the likes of Pfizer, Moderna, Sanofi, BioNTech, CureVac, and more gathered for the world’s only end-to-end meeting focused on the development of mRNA vaccines and therapies from early basic research through to commercialization and to the patients in need.
75+ world-class speakers from large pharma, innovative biotechs, and KOLs of academia convened across 3 days of immersive content covering discovery, pre-clinical & clinical development, manufacturing, analytical development, and supply chain & logistics.
Join us for 2023 to help accelerate your platforms for efficacious mRNA-based therapeutics and vaccines in oncology, infectious and rare diseases, CAR-T cell therapies, and beyond. Register your interest here.
100+ Attending Organizations Included:
Among Our 75+ World-Class Speaker Faculty


Kathy Fernando
VP, Head of Worldwide Research, Development and Medical Operations; Head of mRNA Scientific Planning
Pfizer





